Clinical Trials
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9349
A Randomized Phase II Trial of CHOP with G-CSF Support or ProMACE-CytaBOM with G-CSF Support for Treatment of Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
09-15-1994
Closed
01-15-1997
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9429
Phase II Trial of Carboplatin and VP-16 With Concurrent For Poor-Risk Stage III Non-Small Cell Lung Carcinoma
Research Committee(s)
Lung Cancer
Activated
08-15-1994
Closed
09-01-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9343
Evaluation of Combined Androgen Suppression and Fixed Schedule Suramin in Patients with Newly Diagnosed Metastatic Prostate Cancer, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
08-15-1994
Closed
01-15-1997
Closed
Phase
Accrual
49%
Published
SWOG Clinical Trial Number
SWOG-9219
A Phase II Evaluation of Interleukin-4 (IL-4) in Patients with Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
08-01-1994
Closed
08-01-1999
Closed
Phase
Accrual
39%
Published
SWOG Clinical Trial Number
SWOG-9350
Limited Institution Pilot Trial of Alpha Interferon with Combination Chemotherapy in Disseminated Malignant Melanoma, Phase II
Research Committee(s)
Melanoma
Activated
08-01-1994
Closed
11-13-1996
Closed
Phase
Accrual
4%
SWOG Clinical Trial Number
SWOG-9328 (ECOG-S9328)
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9212
Phase II Trial of Oral Etoposide in Recurrent or Refractory Endometrial Adenocarcinoma
Research Committee(s)
Gynecologic Cancer
Activated
05-15-1994
Closed
01-15-1997
Closed
Phase
Accrual
36%
SWOG Clinical Trial Number
SWOG-9428
Evaluation of DNA Ploidy and p53 in Patients Registered to SWOG-8794 and SWOG-9024, Ancillary
Research Committee(s)
Genitourinary Cancer
Activated
05-15-1994
Closed
12-01-1999
Closed
Phase
Accrual
89%
Published
SWOG Clinical Trial Number
SWOG-9149
A Phase II Study of Cisplatin Preceded by a 12-Hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) for Adult Patients with Malignant Gliomas
Research Committee(s)
Brain Cancer
Activated
05-01-1994
Closed
02-15-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9320
Study of ProMACE-CytaBOM with Trimethoprim Sulfamethoxazole, Granulocyte Colony Stimulating Factor (G-CSF) and Antiretroviral Therapy in Patients with AIDS Related Lymphoma, Phase II
Research Committee(s)
Lymphoma
Activated
05-01-1994
Closed
12-01-2000
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9418
A Pilot Study Evaluating an Educational Program to Increase Utilization of Cervical and Breast Cancer Screening Methods in Hispanic Women
Activated
05-01-1994
Closed
01-01-1996
Closed
Phase
Accrual
85%
Published
SWOG Clinical Trial Number
SWOG-9348
Evaluation of the Standard BCNU/DTIC/Cisplatin/Tamoxifen Regimen in Disseminated Malignant Melanoma, Phase II
Research Committee(s)
Melanoma
Activated
04-15-1994
Closed
04-15-1995
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9208
Health Status and Quality of Life (QL) in Patients with Early Stage Hodgkin's Disease: A companion study to SWOG-9133, Ancillary
Research Committee(s)
Lymphoma
Activated
04-15-1994
Closed
04-24-2000
Closed
Phase
Accrual
98%
Published
SWOG Clinical Trial Number
SWOG-9313
Phase III Comparison of Adjuvant Chemotherapy with High-Dose Cyclophosphamide plus Doxorubicin (AC) versus Sequential Doxorubicin followed by Cyclophosphamide (A’C) in High-Risk Breast Cancer Patients with 0 - 3 Positive Nodes (Intergroup)
Research Committee(s)
Breast Cancer
Activated
03-15-1994
Closed
05-01-1997
Closed
Phase
Accrual
98%
Published
SWOG Clinical Trial Number
SWOG-9304 (INT-0144)
Postoperative Evaluation of 5-FU by Bolus Injection versus 5-FU by Prolonged Venous Infusion Prior to and Following Combined Prolonged Venous Infusion Plus Pelvic XRT Versus Bolus 5-FU Plus Leucovorin Plus Levamisole Prior to and Following Combined Pelvic XRT in Patients with Rectal Cancer, Phase III, Intergroup
Research Committee(s)
Gastrointestinal Cancer
Activated
03-01-1994
Closed
08-01-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9339
Evaluation of Topotecan in Esophageal Carcinoma, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
03-01-1994
Closed
12-15-1995
Closed
Phase
Accrual
90%
Published
SWOG Clinical Trial Number
SWOG-9228
Evaluation of Interleukin-4 (IL-4) in Disseminated Malignant Melanoma, Phase II
Research Committee(s)
Melanoma
Activated
03-01-1994
Closed
09-01-1995
Closed
Phase
Accrual
90%
Published
SWOG Clinical Trial Number
SWOG-9321
Standard Dose Versus Myeloablative Therapy For Previously Untreated Symptomatic Multiple Myeloma
Research Committee(s)
Myeloma
Activated
01-15-1994
Closed
09-15-2000
Closed
Phase
Accrual
75%
Published
SWOG Clinical Trial Number
SWOG-9305 (CALGB-8984)
Evaluation of Topotecan in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, Phase II
Research Committee(s)
Head and Neck Cancer
Activated
01-15-1994
Closed
05-15-1995
Closed
Phase
Accrual
96%
Published
SWOG Clinical Trial Number
SWOG-9235
Phase II Trial of Casodex in Advanced Prostate Cancer Patients Who Failed Conventional Hormonal Manipulation
Research Committee(s)
Genitourinary Cancer
Activated
12-15-1993
Closed
06-01-1994